Federated Hermes Inc. Raises Stock Position in Inogen, Inc. (NASDAQ:INGN)

Federated Hermes Inc. raised its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 16.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 404,273 shares of the medical technology company's stock after purchasing an additional 58,257 shares during the quarter. Federated Hermes Inc. owned approximately 1.70% of Inogen worth $3,707,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of INGN. AlphaQuest LLC purchased a new position in shares of Inogen during the 4th quarter worth approximately $43,000. Meeder Asset Management Inc. purchased a new stake in Inogen in the fourth quarter worth $56,000. Integrated Quantitative Investments LLC bought a new position in Inogen in the fourth quarter worth $92,000. Ieq Capital LLC bought a new stake in shares of Inogen during the 4th quarter valued at $94,000. Finally, Intech Investment Management LLC purchased a new stake in shares of Inogen in the 4th quarter worth about $94,000. Hedge funds and other institutional investors own 89.94% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Needham & Company LLC reissued a "hold" rating on shares of Inogen in a research report on Wednesday, April 9th. StockNews.com downgraded Inogen from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th.

Remove Ads

Inogen Price Performance

Inogen stock traded down $0.12 during mid-day trading on Tuesday, reaching $7.20. The stock had a trading volume of 221,680 shares, compared to its average volume of 240,553. The company has a market capitalization of $193.59 million, a price-to-earnings ratio of -3.20 and a beta of 1.48. Inogen, Inc. has a one year low of $6.40 and a one year high of $13.33. The company has a 50-day moving average price of $8.24 and a two-hundred day moving average price of $9.21.

Inogen Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.